SCHEMBL7870090

SCHEMBL7870090

CC[C@H](C)[C@H](NC(=O)OCc1ccc(OC)cc1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.60
CTSB P07858 3/20 0.56
CTSL P07711 3/20 0.56
CTSS P25774 3/20 0.56
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
LMNA P02545 1/20 0.54
CTSK P43235 3/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
RAB9A P51151 1/20 0.52
ALDH1A1 P00352 2/20 0.51
TYR P14679 1/20 0.51
MME P08473 1/20 0.51
ECE1 P42892 1/20 0.51
CASP3 P42574 1/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870088 1.00 ATM (0.60) ATMCTSBCTSLCTSSMEN1
SCHEMBL5711207 0.88 ATM (0.64) ATMCTSBCTSLCTSSCTSK
SCHEMBL9829383 0.87 ATM (0.63) ATMCTSBCTSLCTSSCTSK
SCHEMBL9829374 0.87 ATM (0.63) ATMCTSBCTSLCTSSCTSK
SCHEMBL24734375 0.87 CTSL (0.71) ATMCTSBCTSLCTSSMEN1
SCHEMBL5145628 0.87 CTSL (0.71) ATMCTSBCTSLCTSSMEN1
SCHEMBL8837339 0.87 CTSL (0.71) ATMCTSBCTSLCTSSMEN1
SCHEMBL7264750 0.87 CTSL (0.71) ATMCTSBCTSLCTSSMEN1
SCHEMBL221434 0.87 CTSL (0.71) ATMCTSBCTSLCTSSMEN1
SCHEMBL8837344 0.87 CTSL (0.71) ATMCTSBCTSLCTSSMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329502-B1 VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS; TREATMENT OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) JAPAN ENERGY CORPORATION (JP) 2001-12-11 US disclosed
US-6313094-B1 COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION JAPAN ENERGY CORPORATION (JP) 2001-11-06 US disclosed
EP-0490667-B1 HIV protease inhibitors JAPAN ENERGY CORP (JP) 1999-06-09 EP disclosed
EP-0490667-A2 HIV protease inhibitors JAPAN ENERGY CORPORATION (JP) 1992-06-17 EP disclosed